Cargando…
Mdm2: Open questions
The Mdm2 oncoprotein and its association with p53 were discovered 30 years ago, and a cornucopia of activities and regulatory pathways have been associated with it. In this review, we will raise questions about Mdm2 and its cousin Mdm4 that we consider worth pursuing in future research, reaching fro...
Autores principales: | Dobbelstein, Matthias, Levine, Arnold J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385351/ https://www.ncbi.nlm.nih.gov/pubmed/32335977 http://dx.doi.org/10.1111/cas.14433 |
Ejemplares similares
-
Mdm2 as a chromatin modifier
por: Wienken, Magdalena, et al.
Publicado: (2017) -
Fortifying p53 – beyond Mdm2 inhibitors
por: Sriraman, Anusha, et al.
Publicado: (2016) -
CDK4 inhibition diminishes p53 activation by MDM2 antagonists
por: Sriraman, Anusha, et al.
Publicado: (2018) -
MDM2-Driven Ubiquitination Rapidly Removes p53 from Its Cognate Promoters
por: Henningsen, Kester Mo, et al.
Publicado: (2021) -
Mdm2 inhibition confers protection of p53-proficient cells from the cytotoxic effects of Wee1 inhibitors
por: Li, Yizhu, et al.
Publicado: (2015)